ライフサイエンスコーパス: cyclodextrin

1 igh-surface-area, mesoporous polymer of beta-cyclodextrin.

2 ally prevented by cholesterol depletion with cyclodextrin.

3 prepared from various omega-3 oils and beta-cyclodextrin.

4 alled carbon nanotubes assimilated with beta-cyclodextrin.

5 of aqueous mixtures of omega-3 oil and beta-cyclodextrin.

6 fts, similar to positive control methyl-beta-cyclodextrin.

7 due is anchored in the interior of the alpha-cyclodextrin.

8 from the film and then solubilized with beta-cyclodextrin.

9 sociation depended on the cavity size of the cyclodextrin.

10 tic rings of curcumin and the cavity of beta-cyclodextrin.

11 lity by increasing the concentration of beta-cyclodextrin.

12 ctively monosubstituted derivatives of gamma-cyclodextrin.

13 pplied to functionalize trans-diols in alpha-cyclodextrin.

14 anoencapsulation of Danube fish oils in beta-cyclodextrin.

15 ules, act as guests in the presence of gamma-cyclodextrin.

16 , 1:2, and 2:1 host-guest complexes with the cyclodextrin.

17 r disruption of lipid rafts with methyl-beta-cyclodextrin.

18 ing neonatal cardiomyocytes with methyl-beta-cyclodextrin.

19 sterol stores were depleted with methyl-beta-cyclodextrin.

20 yl esters form inclusion complexes with beta-cyclodextrin.

21 f new crystalline phases not present in beta-cyclodextrin.

22 rcome by using encapsulating systems such as cyclodextrins.

23 es obtained for the inclusion complexes with cyclodextrins.

24 y encapsulating them into specially designed cyclodextrins.

25 ther deionized water or aqueous solutions of cyclodextrins.

26 aniline or naphthalene moieties of ANS with cyclodextrins.

27 tually continued treatment with itraconazole cyclodextrin, 100 mg twice daily.

28 ids were complexed with 2-hydroxypropyl-beta-cyclodextrin (2-HPbetaCD) in different mass ratios (1:4,

29 ith the sterol acceptor 2-hydroxypropyl-beta-cyclodextrin (2-OHCD) confirmed the release of an active

30 th an extended {[K(OH(2))(6)][AuBr(4)](alpha-cyclodextrin)(2)}n chain superstructure formed during th

31 ependent methods: 1) exposure to methyl-beta-cyclodextrin, 2) treatment with the HMG-CoA reductase in

32 mice were treated with 2-hydroxypropyl-beta-cyclodextrin, a drug previously reported to rescue Purki

33 al neurodegeneration, and we reveal how beta-cyclodextrin, a potential therapeutic drug, reverts thes

34 ented by treatment with 2-hydroxypropyl-beta-cyclodextrin, a promising therapy currently under clinic

35 ollowing treatment with 2-hydroxypropyl-beta-cyclodextrin, a therapy that reduces pathological findin

36 ose of activated carbons and non-porous beta-cyclodextrin adsorbent materials.

37 Neither jasplakinolide nor cyclodextrin affected force or velocity during lamellipo

38 no acid enantiomers were resolved with gamma-cyclodextrin alone.

39 ents of the chemistry of naturally occurring cyclodextrins, along with a variety of synthetic flexibl

40 This study aims to characterize CO2-alpha-cyclodextrin (alpha-CD) inclusion complexes produced fro

41 r-induced crystallization of amorphous alpha-cyclodextrin (alpha-CD) powder on CO2 encapsulation at 0

42 matrices of amorphous and crystalline alpha-cyclodextrin (alpha-CD) powders, under various pressures

43 complexes of trans-anethole (AN) with alpha-cyclodextrin (alpha-CD), beta-cyclodextrin (beta-CD), hy

44 lent complexes of folic acid (FA) and native cyclodextrins (alpha-CD, beta-CD, and gamma-CD).

45 Here we describe the encapsulation in alpha-cyclodextrins (alpha-CDs) of wheat bran, pumpkin and tom

46 or treating cells with low concentrations of cyclodextrin also caused caveolin-1 to accumulate on lat

47 rompted by cholesterol efflux to methyl-beta-cyclodextrin also was prevented, indicating that PM chol

48 reactions of two structurally different beta-cyclodextrins (AmPrbetaCD and AMBnTbetaCD) in the PA(63)

49 Insoluble polymers of beta-cyclodextrin, an inexpensive, sustainably produced macro

50 Methyl beta-cyclodextrin, an inhibitor of caveola formation, reduced

51 ld-bearing raw materials making use of alpha-cyclodextrin-an inexpensive and environmentally benign c

52 r (calorimetric effect of 536Jg(-1) for beta-cyclodextrin and 304-422.5Jg(-1) for complexes).

53 match in molecular recognition between alpha-cyclodextrin and [AuBr(4)](-) leads to a near-axial orie

54 ctivity was only moderately affected by beta-cyclodextrin and bovine serum albumin, taken as models o

55 binding epitopes are capable of binding beta-cyclodextrin and cucurbit[6/7]uril (CB) simultaneously t

56 otease inhibitor batimastat, and methyl-beta-cyclodextrin and filipin, which block lipid raft formati

57 d during the rapid co-precipitation of alpha-cyclodextrin and KAuBr(4) in water.

58 es a background electrolyte containing gamma-cyclodextrin and sodium taurocholate micelles.

59 ivation was also decreased after methyl-beta-cyclodextrin and statin treatment but increased in cells

60 owed a cross-peak between H-3 proton of beta-cyclodextrin and the aromatic rings group of curcumin.

61 after their encapsulation (preloading) into cyclodextrins and administered to mice at higher doses a

62 axane hydrogels, which are composed of alpha-cyclodextrins and poly(ethylene oxide)-poly(propylene ox

63 can accommodate into the hydrophobic core of cyclodextrins and therefore, they are protected from exo

64 erparamagnetic iron oxide nanoparticle, beta-cyclodextrin, and polymerized paclitaxel.

65 Hydroxypropyl-beta-cyclodextrin/ANE (HP-beta-CD/ANE) inclusion complexes we

66 Chitosan chloride and methyl-beta-cyclodextrins appear therefore suitable to formulate sol

67 Cyclodextrins are already known for their ability to enc

68 Cyclodextrins are cyclic oligosaccharides widely used in

69 Cyclodextrins are substances well known for their abilit

70 Cyclodextrins are utilized in many diverse fields of ana

71 Cyclodextrins/aromatic rods, crown ethers/cationic rods

72 g a direct compaction grade powder with beta-cyclodextrin as encapsulating agent.

73 cumin through inclusion complexation by beta-cyclodextrin as well as the topology and geometry of int

74 ycloadditions accelerated in the presence of cyclodextrins as a consequence of self-sorting and posit

75 Cyclodextrins as common chiral selectors were used as mo

76 occupancy of binding sites; (ii) methyl-beta-cyclodextrin, as a FA acceptor, to observe the dissociat

77 ke routes of doxorubicin encapsulated in the cyclodextrin-based carrier were investigated, examining

78 A series of cyclodextrin-based glycoconjugates, including glycoclust

79 Single crystals of a cyclodextrin-based metal-organic framework (MOF) infused

80 per reports evaluation of the potential of a cyclodextrin-based nanocarrier as a drug delivery vehicl

81 e findings demonstrate the promise of porous cyclodextrin-based polymers for rapid, flow-through wate

82 bis(p-sulfonatocalix[4]arene) and the alpha-cyclodextrin-based pseudo[3]rotaxane containing axially

83 es, functionalized with a pH-responsive beta-cyclodextrin-based supramolecular nanovalve on the MS su

84 tive molarity for binding the flexible alpha-cyclodextrin-based template within the six-porphyrin nan

85 Cyclic oligosaccharide 2-hydroxypropyl-beta-cyclodextrin (BCD) is a compound that solubilizes lipoph

86 nsitive host-guest crosslinkers between beta-cyclodextrin (beta-CD) and ferrocene (Fc) and iron chela

87 Here, we show that by attaching beta-cyclodextrin (beta-CD) cavities to reduced graphene-oxid

88 reases with increasing concentration of beta-cyclodextrin (beta-CD) in an aqueous solution, and recov

89 mono-6-deoxy-6-((2-mercaptoethyl)amino)-beta-cyclodextrin (beta-CD) in order to produce a selective c

90 purees through molecular inclusion with beta-cyclodextrin (beta-CD) was assessed.

91 irect complexation with solid amorphous beta-cyclodextrin (beta-CD) was investigated.

92 en rutin and four cyclodextrins, namely beta-cyclodextrin (beta-CD), (2-hydroxypropyl)-alpha-cyclodex

93 AN) with alpha-cyclodextrin (alpha-CD), beta-cyclodextrin (beta-CD), hydroxypropyl-beta-cyclodextrin

94 ion complexes of 2-nonanone (2-NN) with beta-cyclodextrin (beta-CD), were prepared by a co-precipitat

95 Here we report a beta-cyclodextrin (beta-CD)-based polymer network with higher

96 erials, i.e. brown rice flour (BRF) and beta-cyclodextrin (beta-CD).

97 ht-responsive host-guest complexes with beta-cyclodextrin (beta-CD).

98 clic hosts, cucurbit[7]uril (CB[7]) and beta-cyclodextrin (beta-CD).

99 Different wall materials like beta-cyclodextrin (beta-cyd), whey protein isolate (WPI) and

100 Here, we show that beta cyclodextrins (beta-CDs) bind LBs and protect them again

101 LyeTxI and association compound LyeTxI/beta-cyclodextrin (betaCD) against multispecies biofilms.

102 12 cationic peptides were prepared with beta-cyclodextrin (betaCD) at 1:1 molar ratios.

103 olysin (alphaHL) to map the presence of beta-cyclodextrin (betaCD) at a substrate pore opening.

104 se amphiphilic oligoethyleneimine (OEI)-beta-cyclodextrin (betaCD) clusters have been prepared, and t

105 ble sport beverage, with and without 2% beta-cyclodextrin (betaCD) under light and darkness condition

106 thogonal supramolecular interactions of beta-cyclodextrin (betaCD)-adamantyl (Ad) host-guest and N-ni

107 le acid that exhibits strong binding to beta-cyclodextrin (betaCD).

108 ceptor/product, which overlap with the known cyclodextrin binding site.

109 obicity associated with rGO with that of the cyclodextrin cavities and provides a versatile platform

110 ridine ring of folic acid remain outside the cyclodextrin cavity, while the glutamate residue is anch

111 ive capture synthesis, whereby introducing a cyclodextrin (CD) as an accelerator in CB-AAC, hydrogen

112 Induction of cholesterol efflux with cyclodextrin (CD) but not inhibition of cholesterol synt

113 cterization of the rosmarinic acid (RA)-beta-cyclodextrin (CD) complex in aqueous solution by (1)H NM

114 rbonization (TPC) of Cu(2+)- and Fe(3+)-beta-cyclodextrin (CD) complexes, a rapid reduction of Cu(II)

115 nosyl unit in cyclic oligosaccharides of the cyclodextrin (CD) family (cyclomaltohexa-, -hepta-, and

116 F4:Yb/Tm/Er UCNP through an azobenzene (Azo)-cyclodextrin (CD) host-guest interaction.

117 particles were loaded with cargo, bulky beta-cyclodextrin (CD) molecules were noncovalently associate

118 t studies demonstrate that administration of cyclodextrin (CD) to Npc1(-/-) mice eliminates cholester

119 e carriers such as polyamidoamines (PAA) and cyclodextrin (CD)-based polycations are also in a signif

120 The level of released cyclodextrins (CD) was assessed, besides the microstruct

121 cise positions of cyclomaltooligosaccharide (cyclodextrin, CD) macrocycles has proven to be an extrem

122 e controlled release of aroma compounds from cyclodextrins (CDs) and CD polymers was studied by multi

123 Cyclodextrins (CDs) are known molecular encapsulators an

124 cal C-H functionalization to access modified cyclodextrins (CDs) has been developed.

125 Effects of the encapsulation in cyclodextrins (CDs) on the solubility, photostability an

126 Molecular inclusion of OTA by cyclodextrins (CDs) results in complexes with low stabil

127 The capacity of cyclodextrins (CDs) to extract phenolic compounds from g

128 with high biological activity) and modified cyclodextrins (CDs) was studied.

129 alpha-, beta-, and gamma-cyclodextrins (CDs) were modified on their secondary fac

130 Readily available cyclodextrins (CDs) with an inherent hydrophobic interna

131 The cyclodextrins (CDs), cyclic oligosaccharides derived mic

132 Among cyclodextrins (CDs), methyl beta cyclodextrin (MbetaCD)

133 ; this could be resolved by encapsulation in cyclodextrins (CDs).

134 ntation of the ion with respect to the alpha-cyclodextrin channel, which facilitates a highly specifi

135 amin inhibitors, chlorpromazine, methyl-beta-cyclodextrin, chloroquine, and concanamycin A dramatical

136 tion and bioelectrocatalysis of redox-active cyclodextrin-coated nanoparticles.

137 ve scale by HPLC, using a permethylated beta-cyclodextrin column.

138 ess cholesterol by a cholesterol/methyl-beta-cyclodextrin complex, phenocopying SR-BI KO oocytes.

139 The formed extract: beta-cyclodextrin complexes and a physical mixture of extract

140 ch, the first examples of close analogues of cyclodextrins composed of d-glucose residues and triazol

141 -EtOH); 2) 0.5 mg simvastatin in alendronate-cyclodextrin conjugate (SIM-ALN-CD); 3) EtOH alone; 4) A

142 nt host-guest interactions between a polymer-cyclodextrin conjugate and a polymer-paclitaxel conjugat

143 ivalent host-guest interactions between beta-cyclodextrin-conjugated superparamagnetic iron oxide nan

144 clodextrin (RAMEB) and a low methylated-beta-cyclodextrin (CRYSMEB) were investigated in aqueous solu

145 Selected examples for guest binding to cyclodextrins, cucurbit[n]urils, DNA, serum albumins and

146 ecent success using synthetic derivatives of cyclodextrins, cucurbiturils, and various organic cyclop

147 2-hydroxypropyl-beta-cyclodextrin (CYCLO), a modifier of cholesterol efflux f

148 The moisture content of beta-cyclodextrin/Danube fish oils complexes (common barbel,

149 srupting lipid raft formation by methyl-beta-cyclodextrin decreased NO production and apoptosis.

150 re we measured the rate at which methyl-beta-cyclodextrin depletes cholesterol from a supported lipid

151 obutyl ether-beta-cyclodextrin (SCD), a beta-cyclodextrin derivative carrying ionizable groups to ren

152 bTbK in complex with captisol (CAP), a beta-cyclodextrin derivative, host-guest assembling offers a

153 Cyclodextrin derivatives can be utilized as anti-infecti

154 concentration as cholesterol depletion using cyclodextrins did not alter inflammatory responses.

155 asites with cholesterol-specific methyl-beta-cyclodextrin disrupts both membrane liquid order and loc

156 Polyethyleneimine (PEI), Dimethyl-beta-cyclodextrin (DM-beta-CD) and Chitosan enhanced the bioa

157 A combined approach based on cyclodextrin/drug inclusion complex formation and loadin

158 othion inside the cavity of per-6-amino-beta-cyclodextrin:Eu(III) complex.

159 ssociation behavior of the folic acid toward cyclodextrins evaluated by thermodynamic calculations in

160 Methyl-beta-cyclodextrin extracted OA from individual sites in the r

161 Cyclodextrin extractions, sorptive bioaccessibility extr

162 frared fluorophores for bioimaging, and beta-cyclodextrins for potential drug delivery.

163 s (1 mM cholesterol@randomly methylated-beta-cyclodextrin) for transport assays.

164 omarker avoiding the use of additives (i.e., cyclodextrins) for enantiomeric separation as well as an

165 f HSV-1-infected Vero cells with methyl beta-cyclodextrin from 2 to 9 h postentry reduced plaque numb

166 rategy for controlled synthesis of thio-beta-cyclodextrin functionalized graphene/gold nanoparticles

167 ining either cyclodextrin vesicles (CDVs) or cyclodextrin-functionalized gold nanoparticles (CDAuNPs)

168 newable framework material composed of gamma-cyclodextrin (gamma-CD) and alkali metal salts--namely,

169 allization of K(+) and Li(+) ions with gamma-cyclodextrin (gamma-CD) has been shown to substitute the

170 cinnamates using a catalytic amount of gamma-cyclodextrin (gamma-CD) in water has been developed to g

171 -rich cluster [Ta6Br12(H2O)6](2+), and gamma-cyclodextrin (gamma-CD).

172 formation of inclusion complexes with gamma-cyclodextrin (gamma-CD).

173 nsist of an extended porous network of gamma-cyclodextrins (gamma-CDs) and alkali metal cations, can

174 Thymol (THY)/gamma-Cyclodextrin(gamma-CD) inclusion complex (IC) encapsulat

175 alled carbon nanotubes assimilated with beta-cyclodextrin/glassy carbon electrode exhibited catalytic

176 f native and extruded wheat flours combining cyclodextrin glucanotransferase and extrusion treatments

177 2-Hydroxypropyl-beta-cyclodextrin had no effect on transcripts of neuron-spec

178 Cyclodextrins have been shown to reverse lipid accumulat

179 alpha- and beta-cyclodextrins have been used as scaffolds for the synthe

180 Cyclodextrins have been used for decades to improve the

181 ibitors was achieved because per-substituted cyclodextrins have the same symmetry as the target pores

182 ) via controlled esterification or with beta-cyclodextrins (host moieties) through amidation.

183 lodextrin (beta-CD), (2-hydroxypropyl)-alpha-cyclodextrin (HP-alpha-CD), (2-hydroxypropyl)-beta-cyclo

184 extrin (HP-alpha-CD), (2-hydroxypropyl)-beta-cyclodextrin (HP-beta-CD) and (2-hydroxypropyl)-gamma-cy

185 y, were spray-dried using hydroxypropyl-beta-cyclodextrin (HP-beta-CD) and inulin (IN).

186 2-Hydroxypropyl-beta-cyclodextrin (HP-beta-CD) has emerged as a promising int

187 the cycloheptaglucoside 2-hydroxypropyl-beta-cyclodextrin (HP-beta-CD) has shown efficacy as a potent

188 a-cyclodextrin (beta-CD), hydroxypropyl-beta-cyclodextrin (HP-beta-CD), randomly methylated-beta-cycl

189 rin (HP-beta-CD) and (2-hydroxypropyl)-gamma-cyclodextrin (HP-gamma-CD), and the effects of the compl

190 omes was investigated using hydroxypropyl-ss-cyclodextrin (HP-ss-CD) as membrane protectant.

191 s solubility and stability using hydropropyl-cyclodextrins (HP-CDs) and bile salts.

192 h maltodextrin (MD) and 2-hydroxypropyl-beta-cyclodextrin (HPBCD).

193 2-Hydroxypropyl-beta-cyclodextrin (HPbetaCD) is a Food and Drug Administratio

194 n combines this drug with hydroxypropyl-beta-cyclodextrin (HPbetaCD) to improve its solubility and to

195 eported ototoxicity of 2-hydroxypropyl- beta-cyclodextrin (HPbetaCD), a cholesterol chelator and the

196 2-Hydroxy-propyl-beta-cyclodextrin (HPbetaCD), a cholesterol scavenger, is cur

197 and Gallic acid (GA) with 2-hydroxypropyl-b-cyclodextrin (HPbetaCD), by the spray-drying method, wer

198 agents, in particular, 2-hydroxypropyl-beta-cyclodextrin (HpbetaCD).

199 urthermore, we utilized 2-hydroxypropyl-beta-cyclodextrin (HPbetaCD, an emerging therapeutic) adminis

200 Three types of modified cyclodextrin (HPbetaCD, MbetaCD, and HPgammaCD) were use

201 In preclinical testing, 2-hydroxypropyl-beta-cyclodextrins (HPbetaCD) significantly delayed cerebella

202 ct time, using sequential hydroxypropyl-beta-cyclodextrin (HPCD) extractions in soils amended with 0,

203 om long chain ionic surfactants) and neutral cyclodextrins (i.e., native alpha-, beta-, or gamma-cycl

204 e disruption of SM-rich rafts by methyl-beta-cyclodextrin impaired myosin activation and clot retract

205 This study shows a natural example of cyclodextrins improving the solubility and efficacy of a

206 junction with dynamic complexation via alpha-cyclodextrin in an unmodified fused-silica capillary und

207 onse to postprandial micelles or methyl-beta-cyclodextrin in cultured enterocytes, and it is required

208 ylated 2(I)-O-, 3(I)-O- and 6(I)-O-alkylated cyclodextrins in up to 19% yields.

209 cid (PAA) nanofibres (NF) incorporating beta-cyclodextrin inclusion complex (beta-CD-IC) of quercetin

210 ment in the thermal stability of linalool by cyclodextrin inclusion complexation.

211 Melarsoprol cyclodextrin inclusion complexes have been tested in a h

212 glutathione thiyl radical (GS(*)); (ii) beta-cyclodextrins increase the kinetic stability of the spin

213 leting cellular cholesterol with methyl-beta-cyclodextrin increased the resilience of stromal cells t

214 crystalline phases not present in pure beta-cyclodextrin, indicating true complexation.

215 led that the therapeutic drug candidate beta-cyclodextrin induces the subplasmalemmal location of lam

216 3L-1 adipocytes, apoAI, HDL, and methyl-beta-cyclodextrin inhibited chemotactic factor expression.

217 ion of membrane cholesterol with methyl-beta-cyclodextrin inhibited infection by virions but had no e

218 rs, biofilm disruptors, gallium-based drugs, cyclodextrin inhibitors of pore-forming toxins, anti-fun

219 Cyclodextrin insulation of the conjugated backbone impro

220 beta-cyclodextrin is known to encapsulate pollutants to form

221 xtrins (i.e., native alpha-, beta-, or gamma-cyclodextrin) is presented.

222 spinning of polymer-free nanofibrous webs of cyclodextrin/linalool-inclusion complex (CD/linalool-IC-

223 olve this problem, we show that methyl-alpha-cyclodextrin (MalphaCD)-catalyzed lipid exchange can be

224 Among cyclodextrins (CDs), methyl beta cyclodextrin (MbetaCD) is the most efficient to deplete

225 the cholesterol-extracting agent methyl-beta-cyclodextrin (MbetaCD) not only disrupted the DRM locali

226 Treatment of cells with methyl-beta-cyclodextrin (MbetaCD) significantly reduced the DRM ass

227 promastigotes were treated with methyl-beta-cyclodextrin (MbetaCD), a sterol-chelating reagent, caus

228 tment with lipid raft disruptor (Methyl-beta-cyclodextrin, MbetaCD) and oxidative stress inhibitor (N

229 pletion of cholesterol with 5 mm methyl-beta-cyclodextrin (MCD) caused a substantial increase in the

230 In parallel, beta-cyclodextrin mediated the NPC1-independent redistributio

231 rcumin has been successfully encapsulated in cyclodextrin-metal organic frameworks (CD-MOFs) without

232 rs, polymers, oligonucleotides, calixarenes, cyclodextrins, microarrays, vesicles) and to evaluate th

233 Spherical chitosan chloride and methyl-beta-cyclodextrin microparticles loaded with DFO (DCH and MCD

234 brane cholesterol depletion with methyl-beta-cyclodextrin mimicked the effects of AC6 silencing on PA

235 Our cyclodextrin-modified dendritic polyamine construct (ter

236 nt equipped with a noncovalently bound gamma-cyclodextrin molecule as a stochastic sensor.

237 r inclusion complexes between rutin and four cyclodextrins, namely beta-cyclodextrin (beta-CD), (2-hy

238 The use of dynasore, PitStop2, methyl-beta-cyclodextrin, nystatin, and filipin (specific inhibitors

239 ond type interaction between the OH group of cyclodextrin of CD-MOFs and the phenolic hydroxyl group

240 Depletion of cholesterol through methyl-beta-cyclodextrin or cholesterol oxidase abolished the protec

241 by lipid raft perturbation using methyl-beta-cyclodextrin or cholesterol oxidase.

242 y pretreatment of the cells with methyl-beta-cyclodextrin or Filipin III, hence implicating membrane

243 ANS complexation by cyclodextrins or bovine serum albumin (BSA) results in a

244 orrespondingly, pharmacological (methyl-beta-cyclodextrin) or genetic disruption of caveolae (Cav-1 k

245 ds or pretreatment of cells with methyl-beta-cyclodextrin) or osmotic protection of target cells inhi

246 tic material, namely, poly(p-phenylene) beta-cyclodextrin poly(ethylene glycol) (PPP-CD-g-PEG) combin

247 s to evaluate the performance of porous beta-cyclodextrin polymers (P-CDP) as adsorbents of MPs in aq

248 t complexes, but until now cross-linked beta-cyclodextrin polymers have had low surface areas and poo

249 on compound of alamandine/beta-hydroxypropyl cyclodextrin produced a long-term antihypertensive effec

250 Cyclodextrins, provide a hydrophobic cavity in the core

251 d cholesterol accessibility to extraction by cyclodextrin, providing the mechanistic link between cel

252 we demonstrate that quaternary ammonium beta-cyclodextrin (QABCD) fulfils both of these requirements.

253 xtrin (HP-beta-CD), randomly methylated-beta-cyclodextrin (RAMEB) and a low methylated-beta-cyclodext

254 ts with the inhibitory effect of methyl-beta-cyclodextrin reported for other P2X subtypes.

255 Ae. aegypti cells with 2-hydroxypropyl-beta-cyclodextrin restores dengue replication in Wolbachia-ca

256 ation of compound 2 in PLGA nanoparticles or cyclodextrins resulted in lower in vitro toxicity when c

257 gins, using chiral gas chromatography (gamma-cyclodextrin), revealing the exclusive presence of the S

258 y coupling reduced graphene oxide with gamma-cyclodextrin (rGO/gamma-CD).

259 By switching the motion of the alpha-cyclodextrin rings between random shuttling and stationa

260 fol was complexed with sulfobutyl ether-beta-cyclodextrin (SCD), a beta-cyclodextrin derivative carry

261 at is palmitoylated and mediates methyl-beta-cyclodextrin-sensitive self-association of purified gB.

262 micellar solution followed by injection of a cyclodextrin solution zone, and then separation by co-el

263 d was dissolved in 5-10% beta-hydroxy propyl cyclodextrin solution.

264 eation of alpha-cyclodextrin through CymA, a cyclodextrin-specific channel from Klebsiella oxytoca.

265 Inclusion of CHAs with beta-cyclodextrin strongly limited these interactions to a le

266 est score (5/8) along with complexation with cyclodextrin suggesting that these methods are the most

267 the one exception of fullerenes with a gamma-cyclodextrin surface chemistry.

268 eversal is caused by the formation of stable cyclodextrin-surfactant complexes at the boundary that s

269 uble drugs than was previously possible with cyclodextrin technology.

270 The transfer of chirality from the cyclodextrin templates to their nanoring hosts is eviden

271 s, their charged forms complex stronger with cyclodextrins than the neutral ones do.

272 the cholesterol chelating agent, methyl-beta-cyclodextrin, that is thought to disrupt lipid rafts.

273 dverse event in NPC1 patients receiving i.v. cyclodextrin therapy.

274 ore by investigating the permeation of alpha-cyclodextrin through CymA, a cyclodextrin-specific chann

275 of the EOF when analyzing the penetration of cyclodextrins through the CymA pore.

276 g strategy in which applying methylated beta-cyclodextrin to the culture medium allows the sequestrat

277 been synthesized by covalently linking beta-cyclodextrin to the surface of N, S codoped carbon dots

278 Some cells were incubated with methyl-beta-cyclodextrin (to deplete cholesterol from membranes) or

279 ubic structure containing units of six gamma-cyclodextrin tori linked together in cube-like fashion b

280 depleting endogenous 7-DHC with methyl-beta-cyclodextrin treatment enhances Hedgehog activation by a

281 ed to approximately 79 pN/mum by methyl-beta-cyclodextrin treatment to sequester membrane cholesterol

282 awson-type [P2W18O62](6-) anion by two gamma-cyclodextrin units.

283 aints imposed on them, and the properties of cyclodextrin used as a cholesterol donor.

284 es between red bell pepper pigments and beta-cyclodextrin using two different procedures (i.e., magne

285 ed supramolecular systems, containing either cyclodextrin vesicles (CDVs) or cyclodextrin-functionali

286 lymer-shelled vesicles are prepared by using cyclodextrin vesicles as supramolecular templates and an

287 The mass ratio of extract to beta-cyclodextrin was 1:4.

288 ither NPC1-null or NPC2-deficient cells with cyclodextrin was effective in reducing cholesterol stora

289 f the title compound in the presence of beta-cyclodextrin was examined in different conditions.

290 s and a physical mixture of extract and beta-cyclodextrin were evaluated by differential scanning cal

291 Cy3-labeled cyclodextrins were immobilized on a glass surface as a s

292 or goal was to develop a chemically modified cyclodextrin which gives a more stable complex with OTA

293 dentified by NMR as alpha-, beta-, and gamma-cyclodextrins, which undergo acetylation.

294 Regioselective alkylation of gamma-cyclodextrin with allyl or propargyl bromide, using opti

295 Here we crosslink beta-cyclodextrin with rigid aromatic groups, providing a hig

296 evertheless mediates efficient OM passage of cyclodextrins with diameters of up to approximately 15 A

297 on complexes between alpha-, beta- and gamma-cyclodextrins with KAuBr(4) and KAuCl(4), we hypothesize

298 nist or disrupting caveolae with methyl-beta-cyclodextrin, with an associated approximately 30% whole

299 n complexes of Vitamin A Palmitate with beta-cyclodextrins, without the use of organic solvents, is d

300 The dynamic boundary was formed at the cyclodextrin zone as the micelles penetrated this zone.